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Introduction 
 
Amyotrophic lateral sclerosis, also known as ALS, is a progressive 
neurodegenerative disease that affects nerve cells in the brain and spinal cord and has no 
known cure or effective treatment. A well-known symptom of ALS is the gradual onset of 
painless progressive muscle weakness, eventually reaching the lungs resulting in the 
inability to breath. After diagnosis, the average life expectancy of a person is only two to 
five years.  This disease is extremely impacting as more than 5,600 people in the United 
States are diagnosed with ALS each year, and it is estimated that over 30,000 Americans 
have ALS at any given time (“ALS Association,” 2016).  
ALS, along with Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease, 
is now known to be associated with defects in the TAR DNA-binding protein named TDP-43 
(Geser et al., 2009). In motor neurons of those affected by ALS, these defects include the 
aggregation of TDP-43 in the cytoplasm and loss from the nucleus (Neumann et al., 2006). 
Part of the clinical symptoms of ALS in humans could be due to either increased presence of 
TDP-43 in the cytoplasm as aggregates (gain of function) or decreased presence the 
nucleus (loss of function), or a combination of both (Hazelett et al., 2012). Using Drosophila 
melanogaster, the Morton Lab has used the TDP-43 ortholog, TBPH, to confirm that loss of 
TBPH results in adult lethality, reduced larval locomotion (Diaper et al., 2013; Feiguin et al., 
2009; Hazelett et al., 2012), as well as defective neuromuscular physiology (Diaper et al., 
2013).  
TDP-43 has many cellular roles, one of them being a regulator for splicing and 
transcription (Buratti & Baralle, 2010). With regards to splicing, analysis of the RNA 
sequencing data of the mutant flies from the loss function experiments identified a number 
of potentially important target genes, including the Drosophila ortholog of the Cav2 
channel, cacophony (cac) (Hazelett et al., 2012).  
Other loss of function studies in mice have shown that the transcripts of the calcium 
channels are potential targets for TDP-43 (Polymenidou et al., 2011). In the Morton Lab fly 
model for TDP-43 loss of function (TBPH null), loss of TBPH results in reduced levels of 
cacophony (Chang et al., 2014). The loss of function model showed late pupal lethality, and 
defective larval crawling that can be rescued by expressing cacophony selectively in motor 
neurons, as well as rescuing with TBPH (Chang et al., 2014). Reduced levels of cacophony 
and altered splicing due to the loss of TBPH, and the presence of this protein at the active 
zone of the neuromuscular junction suggest that cacophony is a target for TDP-43, and is 
potentially connected to motor neuron degradation in patients with ALS (Kawasaki, Zou, 
Xu, & Ordway, 2004).  
 
Figure 1: TBPH null flies show decreased relative expression of cacophony 
compared to wild type flies, rescued by TBPH, as well as APPL and D42 driving 
cacophony (Chang et al., 2014).  
 
Altered RNA splicing seen in TBPH null flies directly resulted in a lower level of 
transcripts that contain exon 7 (Chang et al., 2014). Exon 7 is believed to code for a section 
of the cytoplasmic C-terminal tail of cacophony, a region that is “known to affect 
inactivation and calcium regulation” (Macleod et al., 2006). “Of the 15 predicted cacophony 
transcripts on FlyBase only one, cac-RM, lacks exon 7 suggesting it plays a significant 
physiological role,” though the specific function is unknown (Chang et al., 2014). 
 
Figure 2: Predicted transcripts of cacophony gene, with only one (cac-RM) 
lacking exon 7 (FlyBase).  
 
Figure 3: Expression levels of exon 7 are decreased in TBPH null flies (Chang et al., 2014). 
 
Absence of TBPH results in larvae that have reduced locomotion and are late pupal 
lethal. Due to the lethality, adult phenotypes have not been assessed, however it is known 
that these mutants have altered splicing and an increased number of transcripts that lack 
exon 7, as well as reduced cacophony levels. Using CRISPR/Cas9 mediated genome editing, 
the Morton Lab has also generated flies that completely lack exon 7 in cacophony. These 
flies are adult viable, have defective larval crawling and reduced levels of cacophony 
protein (Morton, 2016). This study aims to assess the phenotypes of adult flies that lack 
exon 7 to better understand its functionality, and determine if a loss of exon 7 in the 
cacophony transcript causes the locomotion defects observed in TBPH null mutants.  
Methods 
 
Fly keeping: 
 
 All flies were reared at 25˚C using standard procedures (Roote & Prokop, 2013). 
  
Generation exon 7(-) Fly Lines: 
 
The Morton Lab generated flies that completely lack exon 7 in cacophony, using 
CRISPR/Cas9 mediated genome editing. The exon 7 portion was replaced by DsRed, 
resulting in exon 7(-) flies identifiable by white eyes and eye specific DsRed. These flies are 
adult viable, have defective larval crawling and reduced levels of cacophony protein 
(Morton, 2016). Two lines were successfully generated, called I2-6 and I2-8, both used in 
this study determine the phenotype of exon 7(-) by comparing activity and survival with 
wild type flies.  
 
Figure 4: Schematic diagram of drosophila genome (edited portion), showing 
the removal of exon 7 and replacement with DsRed (Alexander Law). 
 
Fly Stocks: 
The following GAL4 drivers, provided by the Bloomington stock center, were used to 
express cacophony in their corresponding neurons: APPL-GAL4 which drives expression in 
all neurons, D42-GAL4, a motor neuron driver, OK6-GAL4, a more specific motor neuron 
driver, Cha-GAL4, a sensory and interneuron driver, as well as an x-duplication line which 
includes the full length of the cacophony genome (Vanderwerf et al., 2015; Morton, 2016). 
Each of these drivers is present on one of the four drosophila chromosomes.  
Drosophila melanogaster has one pair of sex chromosomes and three pairs of 
autosomes, however the fourth chromosome harbors very few genes and plays a negligible 
role in this study so it will not be considered here (Roote & Prokop, 2013). Second and 
third chromosome balancer lines were also provided by the Bloomington stock center. 
Second balancer chromosome is named CyO and carries the marker Cy on one chromosome 
and the Gla marker on the other. The third chromosome balancer carries both Tb and Sb on 
one chromosome, and the other (non-balancer) carries the Dr marker. 
Fly Line 
Genotypes 
(female , male) 
I2-6/I2-8 
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
+
+
   ,   
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
+
+
 
APPL-GAL4 
𝐴𝑃𝑃𝐿
𝐴𝑃𝑃𝐿
 ; 
+
+
 ; 
+
+
   ,   
𝐴𝑃𝑃𝐿
𝑦
 ; 
+
+
 ; 
+
+
 
D42-GAL4 
+
+
 ; 
+
+
 ; 
𝐷42
𝐷42
   ,   
+
𝑦
 ; 
+
+
 ; 
𝐷42
𝐷42
 
OK6-GAL4 
+
+
 ; 
𝑂𝐾6
𝑂𝑘6
 ; 
+
+
   ,   
+
𝑦
 ; 
𝑂𝐾6
𝑂𝐾6
 ; 
+
+
 
Cha-GAL4 
+
+
 ; 
𝐶ℎ𝑎
𝐶ℎ𝑎
 ; 
+
+
   ,   
+
𝑦
 ; 
𝐶ℎ𝑎
𝐶ℎ𝑎
 ; 
+
+
 
x-duplication 
+
+
 ; 
+
+
 ; 
𝑑𝑢𝑝
𝑑𝑢𝑝
   ,   
+
𝑦
 ; 
+
+
 ; 
𝑑𝑢𝑝
𝑑𝑢𝑝
 
II Chromosome Balancer 
+
+
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
  ,  
+
𝑦
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
  
III Chromosome Balancer 
+
+
 ; 
+
+
 ; 
𝑇𝑏
𝑆𝑏
  ,  
+
𝑦
 ; 
+
+
 ; 
𝑇𝑏
𝑆𝑏
 
Table 1: Fly lines used in this study, showing the presence 
of I2-6/8, and APPL on the first chromosome, OK6-GAL4, 
Cha-GAL4, and Cyo/Gla on the second, and D42-GAL4, x-
duplication, and Tb/Sb on the third. 
 
Mating Schemes:  
 
A mating scheme was designed using balancer lines to ensure the examined flies 
carried the correct genotypes on each chromosome. For each experiment, crosses were 
made to generate flies that carry the exon 7(-) deletion plus the specific GAL4 driver and 
UAS-cacophony.  
 The provided balancers were crossed with exon 7(-) flies to create lines with 
homogeneous I2-6/I2-8 and the balancer/marker gene. The resulting line was identifiable 
by eye specific DsRed, curly wings and glassy eyes.  
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
+
+
   X   
+
𝑦
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
      
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
+
 ; 
+
+
   &   
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
+
 ; 
+
+
 
 
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
+
 ; 
+
+
   X   
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
+
+
      
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
+
 ; 
+
+
   &   
𝐼2−6/8
𝐼2−6/8
 ; 
𝐺𝑙𝑎
+
 ; 
+
+
 
 
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
+
 ; 
+
+
   X   
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
+
+
      
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
+
 ; 
+
+
   &   
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
+
 ; 
+
+
 
 
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
+
 ; 
+
+
   X   
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
+
 ; 
+
+
      
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
   &   
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
 
 
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
+
 ; 
+
+
   X   
𝐼2−6/8
𝐼2−6/8
 ; 
𝐺𝑙𝑎
+
 ; 
+
+
      
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
   &   
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
 
Figure 5: Mating scheme for homogenous I2-6/I2-8 with second 
chromosome balancer. The third chromosome balancer line with exon 7 
deletion was generated in a similar manner.   
  
 Lines carrying the various UAS-GAL4 drivers and the exon 7 deletion were also 
generated. These flies were identifiable by colored eyes and eye specific DsRed.  
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
   X   
+
𝑦
 ; 
𝐶ℎ𝑎
𝐶ℎ𝑎
 ; 
+
+
    
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
 ; 
+
+
 and 
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
𝐶ℎ𝑎
 ; 
+
+
 
 
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
 ; 
+
+
  X  
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
    
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
 ;
+
+
  &  
𝐼2−6/8
𝐼2−6/8
 ; 
𝐺𝑙𝑎
𝐶ℎ𝑎
 ; 
+
+
 & 
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
  ; 
+
+
 & 
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
𝐶ℎ𝑎
 ; 
+
+
 
 
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
𝐶ℎ𝑎
 ; 
+
+
 X  
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐺𝑙𝑎
 ; 
+
+
    
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
 ;
+
+
  & 
𝐼2−6/8
𝐼2−6/8
 ; 
𝐺𝑙𝑎
𝐶ℎ𝑎
 ; 
+
+
 & 
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
  ; 
+
+
 & 
𝐼2−6/8
𝑦
 ; 
𝐺𝑙𝑎
𝐶ℎ𝑎
 ; 
+
+
  
 
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
 ; 
+
+
  X  
𝐼2−6/8
𝑦
 ; 
𝐶𝑦𝑜
𝐶ℎ𝑎
  ; 
+
+
  
𝐼2−6/8
𝑦
 ; 
𝐶ℎ𝑎
𝐶ℎ𝑎
 ; 
+
+
  &  
𝐼2−6/8
𝐼2−6/8
 ; 
𝐶ℎ𝑎
𝐶ℎ𝑎
 ; 
+
+
 
Figure 6: Mating scheme for homogenous I2-6/I2-8 and Cha-GAL4. Generation of I2-6/I2-8 with D42 
and OK6 were carried out in a similar manner. 
 
 APPL-GAL4 is on the x-chromosome, requiring recombination for the presence of 
both APPL and exon 7(-). These flies were identifiable by colored eyes and eye specific 
DsRed.  
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
+
+
   X   
𝐴𝑃𝑃𝐿
𝐴𝑃𝑃𝐿
 ; 
+
+
 ; 
+
+
      
𝐴𝑃𝑃𝐿
𝐼2−6/8
 ; 
+
+
 ; 
+
+
    
𝐴𝑃𝑃𝐿
𝐼2−6/8
 ; 
+
+
 ; 
+
+
   X   
+
𝑦
 ; 
+
+
 ; 
+
+
     
𝐴𝑃𝑃𝐿,   𝐼2−6/8
+
 ; 
+
+
 ; 
+
+
   &   
𝐴𝑃𝑃𝐿,   𝐼2−6/8
𝑦
 ; 
+
+
 ; 
+
+
    *Recombination   
𝐴𝑃𝑃𝐿,   𝐼2−6/8
+
 ; 
+
+
 ; 
+
+
   X   
𝐴𝑃𝑃𝐿,   𝐼2−6/8
𝑦
 ; 
+
+
 ; 
+
+
       
𝐴𝑃𝑃𝐿,   𝐼2−6/8
𝐴𝑃𝑃𝐿,   𝐼2−6/8
 ; 
+
+
 ; 
+
+
   &   
𝐴𝑃𝑃𝐿,   𝐼2−6/8
𝑦
 ; 
+
+
 ; 
+
+
   
Figure 7: Mating scheme for homogenous I2-6/I2-8 an APPL.  
A fly line with cacophony and exon 7(-) was generated, identifiable by colored eyes 
and eye specific DsRed.  
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝐷𝑟
𝑇𝑏
   X   
+
𝑦
 ; 
+
+
 ; 
𝑐𝑎𝑐
𝑐𝑎𝑐
    
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝐷𝑟
𝑐𝑎𝑐
 & 
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
 
 
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝐷𝑟
𝑐𝑎𝑐
  X   
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝐷𝑟
𝑇𝑏
   
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝐷𝑟
𝑐𝑎𝑐
  & 
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
  & 
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝐷𝑟
𝑐𝑎𝑐
  & 
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
   
 
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
  X   
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝐷𝑟
𝑇𝑏
   
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝐷𝑟
𝑐𝑎𝑐
  & 
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
  & 
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝐷𝑟
𝑐𝑎𝑐
 & 
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
   
 
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
  X  
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝑇𝑏
𝑐𝑎𝑐
   
𝐼2−6/8
𝑦
 ; 
+
+
 ; 
𝑐𝑎𝑐
𝑐𝑎𝑐
  &  
𝐼2−6/8
𝐼2−6/8
 ; 
+
+
 ; 
𝑐𝑎𝑐
𝑐𝑎𝑐
 
Figure 8: Mating scheme for homogenous I2-6/I2-8 and cac.  
 
 
 
 
 
 
 
Flies used for locomotion assays:  
The above resulting I2-6/8-GAL4 driver lines were crossed with the respective I2-
6/8 cacophony line, resulting in homogenous I2-6/8 with GAL4 drivers and cacophony. The 
x-duplication line was simply crossed with I2-6/8 and the progeny was examined. Control 
lines were produced by crossing each parental line with wild type flies on order to compare 
with heterogeneous genotypes for a more accurate control. 
Rescue Line: Control Lines: 
𝐼2−6/8
𝑦
 , 
+
+
 , 
𝑐𝑎𝑐
+
 
𝐴𝑃𝑃𝐿,   𝐼2−6/8
𝑦
 , 
+
+
 , 
+
+
   
𝐼2−6/8
𝑦
 , 
+
+
 , 
𝑐𝑎𝑐
+
 
𝐼2−6/8
𝑦
 , 
𝐶ℎ𝑎
+
 , 
𝑐𝑎𝑐
+
 
𝐼2−6/8
𝑦
 , 
𝐶ℎ𝑎
+
 , 
+
+
 
𝐼2−6/8
𝑦
 , 
+
+
 , 
𝑐𝑎𝑐
+
 
𝐼2−6/8
𝑦
 , 
+
+
 , 
𝐷42
𝑐𝑎𝑐
 
𝐼2−6/8
𝑦
 , 
𝐶ℎ𝑎
+
 , 
+
+
 
𝐼2−6/8
𝑦
 , 
+
+
 , 
𝑐𝑎𝑐
+
 
𝐼2−6/8
𝑦
 , 
+
+
 , 
𝑑𝑢𝑝
+
 
+
𝑦
 , 
+
+
 , 
𝑑𝑢𝑝
+
  
Table 2: Flies (genotypes) used for locomotion assays.  
 
 Locomotion Assays: 
 
To monitor activity patterns and survival of male flies, a bioactivity monitoring 
system made by TriKinetics was used. Within a 25˚C incubator, each fly was placed in a 65-
mm long tube containing an infrared beam at the midline, as flies crossed the midline photo 
beam breaks are recorded by a computer. At one end of the tube was a fly food solution of 
5% sucrose and 2% agarose. Flies treated with caffeine were given the same solution with 
25mmol of caffeine.  Locomotion was measured by how many times the flies cross the 
beam. Time of death was determined by the last time of activity prior to 24 hours of 
inactivity.  
 
 
 
 
Results 
 
Previous studies show I2-8 and I2-6 flies have reduced levels of cacophony protein 
as well as reduced larval locomotion. This study explores activity and survival in adult flies. 
The results shown in Figure 5 demonstrate that adults with the exon 7(-) genotype have 
reduced locomotion compared to wild type flies, as well as decreased ability to survive 
with exposure to 25mmol of caffeine. It was intended to assess the activity of flies with 
caffeine, but the animals died too quickly under those conditions to get sufficient data.  
 
A. B.  
Figure 5: Exon 7(-) flies show reduced activity without treatment and decreased survival 
with caffeinated food compared to control flies, using ANOVA analysis and Dunnett’s 
multiple comparisons test comparing both lines to W1118 where ****p<0.0001. A) 
Survival is significantly reduced in I2-8 flies (n=32) and in I2-6 flies (n=37), compared to 
W1118 flies (n=32). B) Activity with no treatment was significantly reduced in I2-8  
(n=32) and in I2-6 flies (n=36), compared to W1118 flies (n=32).  
 
  
 Whether these defects are due to absence of exon 7 and decreased levels of 
cacophony, in all cells, motor neurons, sensory neurons, or all neurons, is further explored 
by driving or duplicating the cacophony genome in those cell categories. Duplicating the 
cacophony genome and theoretically restoring the splicing pattern and expression levels of 
cacophony in all cell types was first assessed.  
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Figure 6: Rescue results for X-duplication flies with ANOVA analysis and Dunnett’s 
multiple comparisons test, comparing all lines with W1118 where ****p<0.0001, 
**p=0.0016, *p<0.0255. A) W1118 flies with duplicated cacophony (n= 36) show 
significantly increased activity compared to W1118 (n=32). I2-8 flies with duplication 
(n=24) show rescued activity, though significantly different from W1118. I2-6 flies with 
duplication(n=34) show rescued activity levels compared to W1118, though significantly 
different. B) W1118 flies with duplicated cacophony show increased survival (n=36) 
compared to W1118 (n=32). I2-8 (n=25) and I2-6 (n=34) flies with duplicated cacophony 
do not show rescued survival.  
 
The finding that W1118 flies have increased activity with the duplication confirms 
that an extra copy of the cacophony genome increases activity in Drosophila. W1118 also 
has increased survival with the x-duplication indicating that cacophony levels may affect 
the ability of these animals to survive caffeine. Decreased activity levels seen in I2-8 and I2-
6 is rescued in both lines with an x-duplication, though levels are significantly different 
from W1118. This result suggests that the reduced activity seen in I2-8 and I2-6 is due to 
the absence of exon 7, specifically whether the defects are due to the absence itself or the 
resulting reduced level of cacophony cannot be determined by these results. This would 
require further research.  
W
11
18
W
11
18
;;
du
p/
+
I2
-8
I2
-8
;;
du
p/
+
I2
-6
I2
-6
;;
du
p/
+
0
500
1000
1500
X-duplication 
Total Activity in 24 Hours
No Treatment
A
c
ti
v
it
y
 C
o
u
n
t **** **** ******** **
W
11
18
W
11
18
;;
du
p/
+
I2
-8
I2
-8
;;
du
p/
+
I2
-6
I2
-6
;;
du
p/
+
0
20
40
60
X-duplication 
Mean Survival
25mmol Caffeine
H
o
u
rs
* **** **** **** ****
The duplication rescue restores cacophony expression in all cells and rescues 
locomotion defects in flies lacking exon 7. The follow-up experiments to this study will test 
the effect of using the following UAS-GAL4 drivers for cacophony: APPL-GAL4 which drives 
expression in all neurons, D42-GAL4, a motor neuron driver, and Cha-GAL4, a sensory and 
interneuron driver. The following data shows preliminary results of rescue experiments. 
Between 14 and 22 subjects were used per experiment, and data is not analyzed for 
statistical significance as values may change with future trials.  
APPL driving cacophony preliminary results show increased activity and survival in 
both I2-6 and I2-8 lines, however, the levels in I2-6 are noticeably higher. If this trend 
continues with further trials, it may suggest that there are differences in the I2-6 and I2-8 
background. Further, it is interesting that in all three experiments, the I2 lines show 
increased activity and survival with only UAS cacophony and no GAL4 driver. This may 
suggest something else is going on with the background of the I2 cacophony stocks, and 
will be evaluated in further trials.  
 
 Figure 7: Preliminary data for APPL driving cacophony expression in all neurons 
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The D42 rescue has thus far only been conducted with I2-6 flies. Preliminary results show 
an increase in activity that is greater than the W1118 control line, but not the same for survival.  
 
 Figure 8: Preliminary data for D42 driving cacophony in motor neurons in I2-6 
flies  
 
 Cha driving cacophony expression in sensory and interneurons, so far shows a 
difference in the I2-6 and I2-8 levels of activity and survival.  
 
Figure 9: Preliminary data for Cha driving cacophony expression in sensory and 
interneurons 
 
In terms of the assessment that is to be made about whether the defects of I2 flies 
are due to absence of exon 7 and decreased levels of cacophony, in all cells, all neurons, 
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motor neurons, sensory neurons, no assertion can be made with the preliminary data at 
hand. Further trials may show distinctions between activity and survival between lines 
driving cacophony expression in different sets of neurons. If there is a difference, more will 
be known about which neurons are most affected by the exon 7 deletion.  
Discussion:  
 
According to researchers at Oregon Health and Science University, “as cacophony 
mediates some of the physiological effects of TBPH loss, it is a good candidate to explore as 
a pharmacological target for ALS therapies” (Chang et al., 2014).  A stipulation to this is that 
it is unknown whether there is a change in exon 7 in ALS patients. However, we do know 
that other animal models suggest that cacophony is a target gene (Morton, 2016). The data 
collected in this study is a valuable contribution to what is currently known about the 
causative events in ALS if similar effects of cacophony or exon 7 is found in human patients, 
this could be helpful in developing treatment methods. 
 Further studies need to be conducted in order to determine the specific function of 
exon 7 in its involvement with ALS. This study demonstrates that a lack of this exon results 
in reduced locomotion and is rescued by increased cacophony expression. Whether exon 7 
has other symptomatic affects that are unrelated to cacophony expression need to be 
explored.  
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